NASDAQ:GH
Guardant Health, Inc.
- Stock
industry
Diagnostics & Researchexchange
NASDAQ Global Selectwebsite
guardanthealth.comipo date
Oct 04, 2018full time employees
1,793currency
USD
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus
founders
- AmirAli Talasaz
- Carlos Virella
- Helmy Eltoukhy
investors
Partners | Funding Round | Investor Name | Lead Investor |
---|---|---|---|
Brogan Harris | Post-IPO Equity - Guardant Health | Baillie Gifford | Yes |
— | Venture Round - Guardant Health | Musea Ventures | — |
— | Venture Round - Guardant Health | Plug and Play | — |
— | Secondary Market - Guardant Health | EquityZen | — |
— | Secondary Market - Guardant Health | Storm Global | No |
— | Series E - Guardant Health | Sequoia Capital | No |
Samir Kaul | Series E - Guardant Health | Khosla Ventures | No |
— | Series E - Guardant Health | Temasek Holdings | No |
— | Series E - Guardant Health | C.M. Capital Advisors | No |
Christopher Schaepe, David Chen | Series E - Guardant Health | Lightspeed Venture Partners | No |
investments
Money Raised | Funding Round | Lead Investor | Announced Date | Organization Name |
---|---|---|---|---|
$26M | Series C - Lunit | Yes | 19-07-2021 | Lunit |
acquisitions
Price | Acquiree Name | Announced Date | Transaction Name |
---|---|---|---|
— | Bellwether Bio | 28-03-2019 | Bellwether Bio acquired by Guardant Health |
num employees
- 1001-5000
funding rounds
Money Raised | Announced Date | Lead Investors | Transaction Name | Number of Investors |
---|---|---|---|---|
$90.7M | 21-12-2023 | Baillie Gifford | Post-IPO Equity - Guardant Health | 1 |
$250M | 22-05-2023 | — | Post-IPO Equity - Guardant Health | — |
— | 06-08-2018 | — | Venture Round - Guardant Health | 2 |
— | 16-07-2018 | — | Secondary Market - Guardant Health | 2 |
$360M | 11-05-2017 | SoftBank Vision Fund | Series E - Guardant Health | 9 |
$100M | 07-01-2016 | OrbiMed | Series D - Guardant Health | 10 |
$50M | 03-02-2015 | Lightspeed Venture Partners | Series C - Guardant Health | 7 |
$30M | 22-04-2014 | Khosla Ventures | Series B - Guardant Health | 5 |
$10M | 11-02-2014 | Sequoia Capital | Series A - Guardant Health | 5 |
— | 08-06-2012 | — | Seed Round - Guardant Health | 2 |